Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy

British Journal of Radiology

Volumn 79, Issue 942, 2006, Pages 504-509

  Garipaǧaoǧlu, Melahat ^a,b   Tuncel N ^a   Dalmaz, M G ^a   Gulkesen H ^a   Toy, A ^a   Kizildag A U ^a   Koseoglu F G ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Acibadem Institute of Neurological Sciences   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; HUMAN; MAGNITUDE ESTIMATION METHOD; RADIATION APPLICATOR; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; EQUIPMENT DESIGN; FEMALE; HUMANS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECTUM; SCATTERING, RADIATION; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS;

EID: 33745305324     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/33762931     Document Type: Article

References (39)

1. Lanciano R. Optimizing radiation parameters for cervical cancer. Semin Radiat Oncol 2000;10:36-43.
2. Nori D, Dasari N, Allbright RM. Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Semin Radiat Oncol 2002;12:40-52.
3. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-75.
4. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
5. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000,48:201-11.
6. Montana GS, Martz KL, Hanks GE. Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. Int J Radiat Oncol Biol Phys 1991;20:87-93.
7. Katz A, Eifel PJ. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:1417-25.
8. Scalliet P, Gerbaulet A, Dubray B. HDR versus LDR gynecological brachytherapy revisited. Radiother Oncol 1993;28:118-26.
9. Stitt JA, Fowler JF, Thomadsen BR, Buchler DA, Paliwal BP, Kinsella TJ. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992;24:335-48.
10. Hsu WL, Wu CJ, Jen YM, Yen SH, Lin KT, Ger LP, et al. Twice-per-day fractionated high versus continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer: a nonrandomized comparison of treatment results. Int J Radiat Oncol Biol Phys 1995;32:1425-31.
11. Orton CG. Fractionated high dose rate versus low dose rate cervix cancer regimens. Br J Radiol 1991;64:1165-6.
12. Dale RG. The use of small fraction numbers in high dose-rate gynaecological afterloading: some radiobiological considerations. Br J Radiol 1990;63:290-4.
13. Eifel PJ. High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk? Int J Radiat Oncol Biol Phys 1992;24:383-6.
14. Thomadsen BR, Shahabi S, Stitt JA, Buchler DA, Fowler JF, Paliwal BR, et al. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys 1992;24:349-57.
15. Sminia P, Schneider CJ, Fowler JF. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate. Int J Radiat Oncol Biol Phys 2002;52:844-9.
16. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. I. General considerations based on radiobiology. Br J Radiol 1991;64:133-41.
17. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991;21:1425-34.
18. King GC, Bloomer WD, Kalnicki S, Faul CM, Gooding WE, Stockstill TF, et al. Point dose variations with time during traditional brachytherapy for cervical carcinoma. Med Dosim 2000;25:77-80.
19. ICRU International Commission of Radiation Units and Measurements. Dose and Volume Specifications for reporting intracavitary therapy in gynaecology, ICRU report 38, 1985 Bethesda, MD.
20. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
21. Sood B, Garg M, Avadhani J, Gorla G, Malhotra H, Guha C, et al. Predictive value of linear-quadratic model in the treatment of cervical cancer using high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2002;54: 1377-87.
22. Grigsby PW, Georgiou A, Williamson JF, Perez CA. Grigsby Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys 1993;27:725-9.
23. Corn BW, Galvin JM, Soffen EM, Henze G, Schwaibold F. Positional stability of sources during low-dose-rate brachytherapy for cervical carcinoma. Int J Radiat Oncol Biol Phys 1993;26:513-8.
24. Hoskin PJ, Cook M, Bouscale D, Cansdale J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol 1996;40:59-62.
25. Kim RY, Meyer JT, Plott WE, Spencer SA, Meredith RF, Janelle RL, et al. Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation. Radiology 1995;195:419-22.
26. Kim RY, Meyer JT, Spencer SA, Meredith RF, Jennelle RL, Salter MM. Major geometric variations between intracavitary applications in carcinoma of the cervix: high dose rate vs. low dose rate. Int J Radiat Oncol Biol Phys 1996;35:1035-8.
27. Bahena JH, Martinez A, Yan D, Mele E, Edmunson G, Brown D, et al. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator. Int J Radiat Oncol Biol Phys 1998;41:13-9.
28. Hellebust TP, Dale E, Skjonsberg A, Olsen DR. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 2001;60:273-80.
29. Datta NR, Kumar S, Das KJ, Pandey CM, Halder S, Ayyagari S. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38. Radiother Oncol 2001;60:15-24.
30. Huang EY, Lin H, Hsu HC, Wang CJ, Chen HC, Sun LM, et al. High external parametrial dose can increase the probability of radiation proctitis, in patients with uterine cervix cancer. Gynecol Oncol 2000;79:406-10.
31. Ting JY, Wolfson AH, Wu X, Fiedler JA, Abdel-Wahab M, Yang CC, et al. Bladder and rectal doses from external-beam boosts after gynecologic brachytherapy. Radiology 1998;209:825-30.
32. Kim CR, Eaton BA, Stevens KR Jr. Localization of the apex of the vagina: implications for radiation therapy planning. Radiology 1999;212:155-8.
33. Roeske JC, Mundt AJ, Halpern H, Sweeney P, Sutton H, Powers C, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1997;37:351-8.
34. Chao KS, Williamson JF, Grigsby PW, Perez CA. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998;40:397-403.
35. Wolfson AH, Abdel-Wahab M, Markoe AM, Raub WJ Jr, Diaz D, Desmond JJ, et al. A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1997;37:237-42.
36. Gebara WJ, Weeks KJ, Hahn CA, Montana GS, Anscher MS. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses. Radiat Oncol Investig 1998;6:268-75.
37. Fellner C, Potter R, Knocke TH, Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001;58:53-62.
38. Serkies K, Badzio A, Jereczek-Fossa B, Tarnawska Z, Nowak R, Szewczyk P, et al. Rectal doses in intracavitary brachytherapy of gynecological malignancies: comparison of two dosimetric methods. Radiother Oncol 2001;58:37-41.
39. Dale E, Hellebust TP, Skjonsberg A, Hogberg T, Olsen DR. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 2000;47:963-71.